Achilles Therapeutics plc Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Achilles Therapeutics plc quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Achilles Therapeutics plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$17.8M, a 1.62% increase year-over-year.
  • Achilles Therapeutics plc annual Operating Income (Loss) for 2023 was -$75.3M, a 3.99% increase from 2022.
  • Achilles Therapeutics plc annual Operating Income (Loss) for 2022 was -$78.4M, a 22.1% decline from 2021.
  • Achilles Therapeutics plc annual Operating Income (Loss) for 2021 was -$64.2M, a 90.3% decline from 2020.
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$75.3M +$3.13M +3.99% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-04
2022 -$78.4M -$14.2M -22.1% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-04
2021 -$64.2M -$30.5M -90.3% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-04
2020 -$33.7M -$20M -145% Jan 1, 2020 Dec 31, 2020 20-F 2023-03-07
2019 -$13.8M Jan 1, 2019 Dec 31, 2019 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.